Cerebrocortical beta activity in overweight humans responds to insulin detemir

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Tschritter, Otto ^a   Hennige, Anita M ^a   Preissl, Hubert ^a,b   Porubska, Katarina ^a,c   Schäfer, Silke A ^a   Lutzenberger, Werner ^a   Machicao, Fausto ^a   Birbaumer, Niels ^a,d   Fritsche, Andreas ^a   Häring, Hans Ulrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN DETEMIR; SODIUM CHLORIDE; DRUG DERIVATIVE; INSULIN;

ADULT; ARTICLE; BETA RHYTHM; BRAIN CORTEX; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; HYPERINSULINEMIA; INSULIN RESPONSE; LEAN BODY WEIGHT; MAGNETOENCEPHALOGRAPHY; MALE; OBESITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; DRUG EFFECT; PATHOPHYSIOLOGY;

MUS;

ADULT; CASE-CONTROL STUDIES; CEREBRAL CORTEX; FEMALE; HUMANS; INSULIN; MALE; OVERWEIGHT;

EID: 43149120919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001196     Document Type: Article

References (30)

1. Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ Jr, Fisher LD, et al. (1991) Evidence for entry of plasma, insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest 88: 1272-1281.
2. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, et al. (1993) Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92: 1824-1830.
3. Woods SC, Lotter EC, McKay LD, Porte D Jr (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282: 503-505.
4. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, et al. (1998) Obesity, diabetes and the central nervous system. Diabetologia 41: 863-881.
5. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404: 661-671.
6. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, et al. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125.
7. Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382.
8. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, et al. (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434: 1026-1031.
9. Okamoto H, Obici S, Accili D, Rossetti L (2005) Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115: 1314-1322.
10. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, et al. (1998) Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800: 125-135.
11. Born J, Lange T, Kern W, McGregor GP, Bickel U, et al. (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514-516.
12. Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, et al. (2004) Intranasal insulin improves memory in humans. Psychoneuroeudocrinology 29: 1326-1334.
13. Pitcher H (2006) Alzheimer's disease could be "type 3 diabetes". Lancet Neurol 5: 388-389.
14. Messier C, Teutenberg K (2005) The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 12: 311-328.
15. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, et al. (2006) The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study. Proc Natl Acad Sci U S A 103: 12103-12108.
16. Havelund S, Plum A, Ribel U, Jonassen I, Volund A, et al. (2004) The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin. Pharm Res 21: 1498-1504.
17. Kurtzhals P (2004) Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir. Int J Obes Relat Metab Disord 28 Suppl 2 S23-8: S23-S28.
18. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW (2000) Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 49: 1525-1533.
19. Hennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, et al. (2006) Tissue selectivity of insulin detemir action in vivo. Diabetologia 49: 1274-1282.
20. Novitski N, Tervaniemi M, Huotilainen M, Naatanen R (2004) Frequency discrimination at different frequency levels as indexed by electrophysiological and behavioral measures. Brain Res Cogn Brain Res 20: 26-36.
21. Sauseng P, Klimesch W, Doppelmayr M, Hanslmayr S, Schabus M, et al. (2004) Theta coupling in the human electroencephalogram during a working memory task. Neurosci Lett 354: 123-126.
22. Lutzenberger W, Ripper B, Busse L, Birbaumer N, Kaiser J (2002) Dynamics of gamma-band activity during an audiospatial working memory task in humans. J Neurosci 22: 5630-5638.
23. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79.
24. Vardy ER. Hussain I, Hooper NM (2006) Emerging therapeutics for Alzheimer's disease. Expert Rev Neurother 6: 695-704.
25. Seyfert S, Kunzmann V, Schwertfeger N, Koch HC, Faulstich A (2002) Determinants of lumbar CSF protein concentration. J Neurol 249: 1021-1026.
26. Ellmerer M, Schaupp L, Brunner GA, Sendlhofer G, Wutte A, et al. (2000) Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 278: E352-E356.
27. Dea MK, Hamilton-Wessler M, Ader M, Moore D, Schaffer L, et al. (2002) Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake. Diabetes 51: 762-769.
28. Woods SC, Seeley RJ, Baskin DG, Schwartz MW (2003) Insulin and the blood-brain barrier. Curr Pharm Des 9: 795-800.
29. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Haring HU, et al. (2007) Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia. In press DOI 10.1007/s00125-007-0839-1.
30. Fritsche A, Haring H (2004) At last, a weight neutral insulin? Int J Obes Relat Metab Disord 28 Suppl 2:S41-6.: S41-S46.